Sundar PichaiSundar Pichai earned $164M in 2023

Hank Kucheman is the former CEO of Boston Scientific Corporation, a major player in the medical device industry known for producing innovative, less invasive solutions for healthcare. Kucheman took charge as interim CEO at a critical time while the company...

Quick Links
B

Hank Kucheman

Ex-CEO of Boston Scientific

Education

Bachelor's degree in Business Administration from the University of Florida

Field of Expertise

Business & Management

Sector of Economy

Healthcare

Born

December 31, 1951 - 73 years ago

CEO of Boston Scientific for

0 years 10 months (Dec 2011 - Nov 2012)

Previous Experience

Executive Vice President and Group President of Cardiology, Rhythm and Vascular Group

Holdings

See how much did Hank Kucheman make over time.

During his tenure, Hank Kucheman held substantial ownership in Boston Scientific, reflecting personal investment in the company's future. Notably, as of 2012, he had accumulated over $7 million in company stock and stock options. This investment peaked during his transition...

No data yet.

No data yet.

Insider Trading

See recent insider trades of Hank Kucheman.

BSX

$52.09K

BSX at $5.21/share

Jul 31, 2012

Purchase

Compensation History

See how much did Hank Kucheman make over time.

In 2012, Hank Kucheman's total compensation reached approximately $7 million, which included a salary of $900,000 and performance-linked elements without cash bonuses. Interestingly, he emphasized equity over immediate cash rewards, signaling a philosophy that aligned his interests with those of shareholders. His retirement package included over $1 million in vested stock units and other benefits, marking a successful tenure. Kucheman’s structured pay packages revealed his commitment to long-term company performance rather than short-term gains. He prioritized performance metrics, demonstrating an understanding of what drives significant, sustainable progress in the medical technology field. This strategy helped ensure that the leadership at Boston Scientific remained focused on creating value for both patients and investors.

Year

2012

Total Compensation

$4.37M

Salary

$900.00K

Board Justification

The compensation philosophy emphasizes alignment with company performance and retention strategies, with a significant portion of compensation tied to performance metrics.

Bonus

$0.00

Board Justification

No cash bonuses were paid to Mr. Kucheman in 2012.

Other

$1.89M

Board Justification

Includes accrued vacation payout and other retirement benefits.

Restricted Stock

$1.57M(272.21K service-based DSUs)

Board Justification

272,207 shares of service-based DSUs vested upon retirement on December 31, 2012.

Performance Metrics

The performance metrics for 2012 included adjusted EPS and SFX net sales.